Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MATWIN: bridging the gap between academic research and industry.

Josy Reiffers1, Lucia Robert2

  • 1MATWIN, Institut Bergonié, 229 cours de l'Argonne, CS 61283, 33076, Bordeaux cedex, France. josy.reiffers@matwin.org.

Human Genomics
|September 18, 2015
PubMed
Summary

The Maturation and Accelerating Translation With INdustry (MATWIN) program supports innovative cancer research projects. It aims to enhance the industrial attractiveness of these projects to accelerate cancer treatment development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pro-survival role of p62 during granulocytic differentiation of acute myeloid leukemia cells.

Molecular & cellular oncology·2016
Same author

ELN 2013 response status criteria: relevance for de novo imatinib chronic phase chronic myeloid leukemia patients?

American journal of hematology·2014
Same author

Reply to J. Richter et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2014
Same author

[Professor John M. Goldman 1938-2013].

Bulletin du cancer·2014
Same author

Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy.

Haematologica·2013
Same author

Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2013

Area of Science:

  • Oncology
  • Translational Research
  • Biotechnology Commercialization

Background:

  • The Maturation and Accelerating Translation With INdustry (MATWIN) program is a national initiative.
  • It focuses on advancing cancer innovation through industry collaboration.
  • The program supports research projects seeking to improve industrial attractiveness.

Discussion:

  • MATWIN provides dedicated tools, resources, and staff to project leaders.
  • This support is crucial for optimizing the commercial viability of cancer research.
  • The program bridges the gap between academic research and industrial application.

Key Insights:

  • MATWIN accelerates the translation of cancer research findings into tangible applications.
  • It fosters partnerships between researchers and industry stakeholders.

Related Experiment Videos

  • The program enhances the potential for successful commercialization of cancer innovations.

    • Outlook:

    • The initiative aims to significantly contribute to more effective cancer treatments.
    • It is expected to drive progress in the fight against cancer.
    • MATWIN seeks to foster a robust ecosystem for cancer innovation and development.